Author response

摘要

In their opposing thesis, the authors anchor their argument against a class effect mainly on the "inconsistent efficacy" seen with intranasal corticosteroids (INSs) other than fluticasone furoate on reducing ocular symptoms in seasonal allergic rhinitis (SAR).They also refer to the new INS fluticasone furoate as the one INS to consistently demonstrate efficacy on the total ocular symptom score (TOSS).